Master Data

Registry
Register court Köln HRB 110121
Registered
3/30/2022
Industry
Research and experimental development on biotechnologyManufacture of pharmaceutical preparationsManufacture of basic pharmaceutical products
Purpose
Die biotechnische Forschung sowie die Entwicklung, die Herstellung und der Vertrieb biotechnologischer Erzeugnisse und Lösungen aller Art.

History

No events found for this filter

Management

NameRole
Managing Director
Mark Gregory Manfredi
since 11/25/2025
Managing Director

Beneficial Owners

Identified persons (4)

NameOwnership
R**** T*****
6.50%
J******* H********
6.50%
B**** E**** W*********
3.50%

Unresolved chains (5)

Shareholders

10 shareholders

GmbH structure

5 of 10 shown

Sofinnova Capital X FPCI
France
€26,204
20.96%
Merck Ventures B.V.
Netherlands
€15,802
12.63%
AbbVie Central Finance B.V.
Netherlands
€15,802
12.63%
AvH Growth Capital NV
Belgium
€15,470
12.37%
Panakes Partners SGR S.p.A.
Italy
€15,416
12.33%

News & Media Coverage

Insolvency Notices

Current insolvency proceedings

Check if there are any insolvency proceedings for this company

Commercial Register Documents

Shareholder List
Current Print (Aktueller Abdruck)
Chronological Print (Chronologischer Abdruck)

Organizations at this Address

30 nearby organizations

List of companies and organizations located at or near this business address. Data includes company names, addresses, registration details, and industry classifications.
The information on this page is sourced from public sources, official registries, or provided by third-party providers. Fusionbase does not guarantee the accuracy, completeness, or timeliness of the data. If you have any questions or suggestions, feel free to contact us via the contact form.